Evidence map›Paper›PMID 33281990›Full record

ArticleCellular and molecular bioengineering2020

A Chemically Defined Common Medium for Culture of C2C12 Skeletal Muscle and Human Induced Pluripotent Stem Cell Derived Spinal Spheroids.

Rachel R Besser, Annie C Bowles, Ahmad Alassaf, Daniel Carbonero, Renata Maciel, Mario Saporta, Ashutosh Agarwal

Erratum issuedAbstract read
In one paragraph

Article in Cellular and molecular bioengineering, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Optimization of Application-Driven Development ofTissue engineering. Part B, Reviews · 2022
    Review
  9. Review
  10. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Rachel R BesserDepartment of Biomedical Engineering, DJTMF Biomedical Nanotechnology Institute, University of Miami, 1251 Memorial Dr, MEA 203, Coral Gables, FL 33146 USA.
Annie C BowlesDepartment of Biomedical Engineering, DJTMF Biomedical Nanotechnology Institute, University of Miami, 1251 Memorial Dr, MEA 203, Coral Gables, FL 33146 USA.
Ahmad AlassafDepartment of Biomedical Engineering, DJTMF Biomedical Nanotechnology Institute, University of Miami, 1251 Memorial Dr, MEA 203, Coral Gables, FL 33146 USA.
Daniel CarboneroDepartment of Biomedical Engineering, DJTMF Biomedical Nanotechnology Institute, University of Miami, 1251 Memorial Dr, MEA 203, Coral Gables, FL 33146 USA.
Renata MacielDepartment of Neurology, University of Miami Miller School of Medicine, 1120 NW 14th St, Suite 1310, Miami, FL 33136 USA.
Mario SaportaDepartment of Neurology, University of Miami Miller School of Medicine, 1120 NW 14th St, Suite 1310, Miami, FL 33136 USA.
Ashutosh AgarwalDepartment of Biomedical Engineering, DJTMF Biomedical Nanotechnology Institute, University of Miami, 1251 Memorial Dr, MEA 203, Coral Gables, FL 33146 USA.ORCID 0000-0002-2397-9886

Funding

Engineering a Human Physiomimetic Islet MicrosystemUC4DK104208 · NIDDK · UNIVERSITY OF FLORIDA · PI AGARWAL, ASHUTOSH, RICORDI, CAMILLO · 2014 to 2014
$4.9M
Institutional Career Development CoreKL2TR002737 · NCATS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI RUNDEK, TATJANA, SCOTT, GWENDOLYN BARBARA · 2018 to 2022
$3.6M
A comprehensive liquid biopsy platform for detection and prognostication in early stage breast cancerU01CA233363 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI AGARWAL, ASHUTOSH, COTE, RICHARD JAMES · 2018 to 2022
$2.6M
Engineering a Human Microphysiological System for the Characterization of Islet-Immune InteractionsUG3DK122638 · NIDDK · UNIVERSITY OF FLORIDA · PI AGARWAL, ASHUTOSH, BRUSKO, TODD MICHAEL · 2019 to 2020
$2.1M
NCATS NIH HHS KL2 TR002737NCI NIH HHS U01 CA233363NIDDK NIH HHS UC4 DK104208NIDDK NIH HHS UG3 DK122638
6 · The paper itself

Abstract

introductionMulticellular platforms and linked multi organ on chip devices are powerful tools for drug discovery, and basic mechanistic studies. Often, a critical constraint is defining a culture medium optimal for all cells present in the system. In this study, we focused on the key cells of the neuromuscular junction i.e., skeletal muscle and motor neurons.

methodsFormulation of a chemically defined medium for the co-culture of C2C12 skeletal muscle cells and human induced pluripotent stem cell (hiPSC) derived spinal spheroids (SpS) was optimized. C2C12 cells in 10 experimental media conditions and 2 topographies were evaluated over a 14-day maturation period to determine the ideal medium formulation for skeletal muscle tissue development.

resultsDuring early maturation, overexpression of genes for myogenesis and myopathy was observed for several media conditions, corresponding to muscle delamination and death. Together, we identified 3 media formulations that allowed for more controlled differentiation, healthier muscle tissue, and long-term culture duration. This evidence was then used to select media formulations to culture SpS and subsequently assessed axonal growth. As axonal growth in SpS cultures was comparable in all selected media conditions, our data suggest that the neuronal basal medium with no added supplements is the ideal medium formulation for both cell types.

conclusionsOptimization using both topographical cues and culture media formulations provides a comprehensive analyses of culture conditions that are vital to future applications for

Indexed as

Chemically defined mediaCo-culture motor neuronsNeuromuscular junctionOrgans on chipsSkeletal muscle

Identifiers

PMID33281990
PMCPMC7704992

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.